本文翻译正在准备中。在此之前，我们暂时显示英文原文。
商业 · 2021/6/151 分钟阅读
Lederle Laboratories et al.; Withdrawal of Approval of 12 Abbreviated New Drug Applications; Correction
本地自动翻译 · 来源原始语言
摘要
The Food and Drug Administration (FDA) is correcting a notice that appeared in the Federal Register on May 12, 2021. The document announced the withdrawal of approval of 12 abbreviated new drug applications (ANDAs) from multiple applicants, withdrawn as of June 11, 2021. The document indicated that FDA was withdrawing the approval of ANDA 060164, Nystatin Ointment, held by Lederle Laboratories. However, the document published with an incorrect application number for this product. This document corrects that error.
来源原始语言: Federal Register — Food and Drug Administration打开原始公告 →